UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study

BMC medicine, 2023-01, Vol.21 (1), p.11-13, Article 11

2023

Volltextzugriff (PDF)

Manganese ferrite/reduced graphene oxide composites as energy storage electrode materials for supercapacitors

Ionics, 2024-05, Vol.30 (5), p.2957-2967

2024

Volltextzugriff (PDF)

Image enhancement of photoacoustic imaging for early endometrial cancer detection by employing a filtered delay multiply and sum beamforming algorithm

AIP advances, 2019-12, Vol.9 (12), p.125303-125303-6

2019

Volltextzugriff (PDF)

Baicalein inhibits hepatocellular carcinoma cells through suppressing the expression of CD24

International immunopharmacology, 2015-12, Vol.29 (2), p.416-422

2015

Volltextzugriff (PDF)

Circ_0085495 knockdown reduces adriamycin resistance in breast cancer through miR-873-5p/integrin β1 axis

Anti-cancer drugs, 2022-01, Vol.33 (1), p.e166

2022

Volltextzugriff (PDF)

A multicentre randomised trial comparing weekly paclitaxel + S-1 with weekly paclitaxel + 5-fluorouracil for patients with advanced gastric cancer

European journal of cancer (1990), 2013-09, Vol.49 (14), p.2995-3002

2013

Volltextzugriff (PDF)

Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer

Oncology reports, 2012-08, Vol.28 (2), p.439-445

2012

Volltextzugriff (PDF)

CMAB009 plus irinotecan versus irinotecan‐only as second‐line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild‐type metastatic colorectal cancer patients: promising findings from a prospective, open‐label, randomized, phase III trial

Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-13

2019

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Journal of clinical oncology, 2016-05, Vol.34 (13), p.1448-1454

2016

Volltextzugriff (PDF)

Cancer Cell Membrane-Biomimetic Nanoparticles Based on Gelatin and Mitoxantrone for Synergetic Chemo-Photothermal Therapy of Metastatic Breast Cancer

ACS biomaterials science & engineering, 2024-02, Vol.10 (2), p.875-889

2024

Volltextzugriff (PDF)

Surface plasmon resonance hydrogen sensor based on metallic grating with high sensitivity

Optics express, 2008-11, Vol.16 (23), p.18599-18604

2008

Volltextzugriff (PDF)

Band engineering of ZnO/Si nanowire arrays in Z-scheme heterojunction for efficient dye photodegradation

Applied surface science, 2020-11, Vol.529, p.147023, Article 147023

2020

Volltextzugriff (PDF)

An efficient 3D face recognition approach using Frenet feature of iso-geodesic curves

Journal of visual communication and image representation, 2019-02, Vol.59, p.455-460

2019

Volltextzugriff (PDF)

Birefringent azopolymer long period fiber gratings induced by 532 nm polarized laser

Optics communications, 2009-06, Vol.282 (12), p.2348-2353

2009

Volltextzugriff (PDF)

Association of CD44 and CD24 phenotype with lymph node metastasis and survival in triple-negative breast cancer

International journal of clinical and experimental pathology, 2020-01, Vol.13 (5), p.1008-1016

2020

Volltextzugriff (PDF)

Safety, Efficacy, and Pharmacokinetics of Rezivertinib (BPI-7711) in Patients With Advanced NSCLC With EGFR T790M Mutation: A Phase 1 Dose-Escalation and Dose-Expansion Study

Journal of thoracic oncology, 2022-05, Vol.17 (5), p.708-717

2022

Volltextzugriff (PDF)

Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib

BMC medicine, 2023-01, Vol.21 (1)

2023

Volltextzugriff (PDF)

Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes

Medical science monitor, 2017-09, Vol.23, p.4657-4664

2017

Volltextzugriff (PDF)

Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer

Zhongguo fei ai za zhi, 2012-10, Vol.15 (10), p.569-575

2012

Volltextzugriff (PDF)

Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies

Lung cancer (Amsterdam, Netherlands), 2023-06, Vol.180, p.107194-107194, Article 107194

2023

Volltextzugriff (PDF)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis

World journal of surgical oncology, 2015-02, Vol.13 (1), p.56-56, Article 56

2015

Volltextzugriff (PDF)

A phase I study to evaluate safety, tolerability, pharmacokinetics and antineoplastic activity of BPI-7711 in patients with EGFR/T790M mutation advanced or recurrent NSCLC

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9034-9034

2019

Volltextzugriff (PDF)

Abstract PS13-25: Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS13-25-PS13-25

2021

Volltextzugriff (PDF)

Optical bistability enhanced by highly localized bulk plasmon polariton modes in subwavelength metal-nonlinear dielectric multilayer structure

Applied physics letters, 2009-02, Vol.94 (8), p.081117-081117-3

2009

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Life Sciences & Biomedicine
(60)
Humans
(36)
Physical Sciences
(28)
Technology
(24)
Physics
(15)
Animals
(12)
Female
(12)
Oncology
(12)
Pharmacology & Pharmacy
(12)
Chemistry
(11)
Physics, Applied
(11)
Engineering
(10)
Materials Science
(9)
Science & Technology - Other Topics
(9)
Adult
(8)
Aged
(7)
Male
(7)
Materials Science, Multidisciplinary
(7)
Middle Aged
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study

Manganese ferrite/reduced graphene oxide composites as energy storage electrode materials for supercapacitors

Image enhancement of photoacoustic imaging for early endometrial cancer detection by employing a filtered delay multiply and sum beamforming algorithm

Baicalein inhibits hepatocellular carcinoma cells through suppressing the expression of CD24

Circ_0085495 knockdown reduces adriamycin resistance in breast cancer through miR-873-5p/integrin β1 axis

A multicentre randomised trial comparing weekly paclitaxel + S-1 with weekly paclitaxel + 5-fluorouracil for patients with advanced gastric cancer

Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer

CMAB009 plus irinotecan versus irinotecan‐only as second‐line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild‐type metastatic colorectal cancer patients: promising findings from a prospective, open‐label, randomized, phase III trial

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Cancer Cell Membrane-Biomimetic Nanoparticles Based on Gelatin and Mitoxantrone for Synergetic Chemo-Photothermal Therapy of Metastatic Breast Cancer

Surface plasmon resonance hydrogen sensor based on metallic grating with high sensitivity

Band engineering of ZnO/Si nanowire arrays in Z-scheme heterojunction for efficient dye photodegradation

An efficient 3D face recognition approach using Frenet feature of iso-geodesic curves

Birefringent azopolymer long period fiber gratings induced by 532 nm polarized laser

Association of CD44 and CD24 phenotype with lymph node metastasis and survival in triple-negative breast cancer

Safety, Efficacy, and Pharmacokinetics of Rezivertinib (BPI-7711) in Patients With Advanced NSCLC With EGFR T790M Mutation: A Phase 1 Dose-Escalation and Dose-Expansion Study

Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib

Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes

Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer

Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis

A phase I study to evaluate safety, tolerability, pharmacokinetics and antineoplastic activity of BPI-7711 in patients with EGFR/T790M mutation advanced or recurrent NSCLC

Abstract PS13-25: Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study

Optical bistability enhanced by highly localized bulk plasmon polariton modes in subwavelength metal-nonlinear dielectric multilayer structure

Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial

Suchergebnisse filtern